"Sharper Than Ever" Advanced Nootropic

The Advanced Nootropic kit extends the Neuro Core pairing by switching to the acetylated forms of Semax and Selank for extended-stability research, then adds Dihexa and P-21 to bring HGF/c-Met and NGF-related neurotrophic signaling into the same four-peptide research panel.

This kit builds directly on the same two systems studied in the standard Neuro Core pairing, BDNF-related and GABAergic neuropeptide signaling, but substitutes the acetylated analogs for extended-stability research, and adds two additional neurotrophic-signaling peptides that were not part of the original two-peptide pairing. Researchers who have already worked with Semax and Selank individually and want to expand into a broader neurotrophic-signaling panel are the intended audience for this larger kit.

What's Included in This Kit

• Vial 1, Semax Acetyl (30mg): neurotrophic factor (BDNF) research, in the extended-stability acetylated form.
• Vial 2, Selank Acetyl (10mg): GABAergic signaling research, in the extended-stability acetylated form.
• Vial 3, Dihexa (5mg): HGF/c-Met signaling and synaptogenesis research.
• Vial 4, P-21 (5mg): nerve growth factor (NGF)-related neurotrophic signaling research.

Why the Acetylated Forms

Semax Acetyl and Selank Acetyl are studied in the same research areas as their parent compounds, Semax and Selank, but the acetylation is intended to improve formulation stability. Researchers specifically studying stability-related formulation questions, or who prefer the acetylated form for other protocol reasons, are the audience for this kit over the standard Neuro Core pairing.

Dihexa and P-21: Two More Neurotrophic-Signaling Angles

Dihexa is a small-molecule peptide derivative studied for its interaction with hepatocyte growth factor (HGF)/c-Met signaling, an area connected to synaptogenesis research, distinct from both the BDNF and GABAergic systems the other three compounds address. P-21 is a peptide studied in nerve growth factor (NGF)-related research, contributing a fourth neurotrophic-signaling angle to round out the kit. Together, all four compounds span four separate neurotrophic-signaling systems, BDNF, GABAergic, HGF/c-Met, and NGF, rather than four variations on the same one.

Building a Comprehensive Neurotrophic Research Panel

Neurotrophic-signaling research spans multiple growth-factor systems, BDNF, HGF, and NGF each represent separate signaling cascades with their own receptors and downstream effects, even though all three are broadly grouped under neurotrophic research. This kit is structured to represent three of those systems (via Semax Acetyl, Dihexa, and P-21) alongside the GABAergic system Selank Acetyl covers, giving researchers a comparatively comprehensive four-system panel rather than depth in a single pathway.

Dosing and Sourcing Considerations

Because this kit contains four mechanistically distinct compounds at different strengths, researchers typically approach it as four independent variables within a single protocol rather than a single combined intervention. Each peptide's dosing and reconstitution schedule should be planned around its own research question, whether that's BDNF signaling duration, GABAergic receptor engagement, HGF/c-Met pathway activity, or NGF-related signaling, rather than treated as a uniform four-part regimen.

Related Research Bundles

For the standard, non-acetylated version of the Semax/Selank pairing without Dihexa or P-21, see Neuro Core. For sleep and neuroendocrine research that also references Selank, see Recovery, Sleep & Stress. Browse the full Peptide Bundles collection for the complete lineup.

Each of the four vials ships individually labeled with compound name, strength, and batch lot number, none are pre-mixed. Every vial is independently verified through HPLC before batch release.

This product is intended strictly for laboratory research use only. It is not approved for human consumption, therapeutic application, or diagnostic purposes.